Frühes NSCLC: Atezolizumab punktet in der Neoadjuvanz
Crossref DOI link: https://doi.org/10.1007/s15015-021-3425-3
Published Online: 2021-04-20
Published Print: 2021-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kraus, Dagmar
Text and Data Mining valid from 2021-04-01
Version of Record valid from 2021-04-01
Article History
First Online: 20 April 2021